This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

Find out more here.

Care Homes Independent Pharmacist Prescribing Service: CHIPPS

  • Research type

    Research Study

  • Full title

    Care Homes Independent Pharmacist Prescribing Service (CHIPPS): Development and delivery of a cluster randomised controlled trial to determine both its effectiveness and cost-effectiveness

  • IRAS ID

    173232

  • Contact name

    David Wright

  • Contact email

    d.j.wright@uea.ac.uk

  • Duration of Study in the UK

    1 years, 0 months, 1 days

  • Research summary

    The use of medicines in care homes could be improved and as a result the health of resident’s would be better. Pharmacist prescribers (i.e. pharmacists specifically trained to prescribe in a similar way to doctors), have already been shown to provide high quality care, which is safe and well received. We propose to test if making ‘pharmacist prescribers’ part of the care home team, working alongside general practitioners, could improve the use of medicines and the care of residents. These pharmacist prescribers could sign and order monthly prescriptions whilst carefully monitoring how each resident responds.

    We believe that such a change to the management of medicines in care homes is likely to be a good use of NHS money. However, to develop and test this idea in the best way possible we need to undertake six smaller linked work projects (WP). This application is for the first part of this programme – WP1.

    We will start WP1 by updating our knowledge of the research on how best to prescribe and use medicines in care homes. We will then use the expertise of those working in care homes to find out how best to introduce and use pharmacist prescribers so that they become an effective member of the team. At the same time, we need to find the best ways to measure the effect of these pharmacists on residents, staff and the home. To do that, we will need to look at how other researchers have measured the effect of changes in prescribing and rank those methods for suitability.

    This will provide us with information about how we think it will be best to introduce, run and test this new service; this information will inform the next part of the programme – WPs 2-6.

  • REC name

    Yorkshire & The Humber - Sheffield Research Ethics Committee

  • REC reference

    15/YH/0172

  • Date of REC Opinion

    10 Apr 2015

  • REC opinion

    Further Information Favourable Opinion